Tirzepatide

Tirzepatide
Product Description

Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

Read more Show less

Senova Technology Company Limited

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    2023788-19-2
  • Selling Points
    Product Performance; Quality Service; Sustainability
  • Model
    GLP-1
  • Supplied from
    China
  • Measured In
    gram
More specifications Fewer specifications
Sales Markets
Show more Show less

Senova Technology Company Limited

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
View company profile

More Products from Senova Technology Company Limited (2)

  • Semaglutide

    Product Semaglutide

    Semaglutide(910463-68-2) is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to im...
  • Mazdutide

    Product Mazdutide

    Mazdutide is a co-agonist of glucagon-like peptide (GLP-1R) and glucagon receptor (GCGR)